Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses
CA 2467006 A1 · Owner: Abic Biological Laboratories Teva Ltd. · Inventors: Smith, Nicolas C.; Wallach, Michael; Belli, Sabina I.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is drown to recombinant 86 kD 56 kD, 30k D and 14 kD , antigens, expressed in expression system using the plasmid pTrcHis. Further the claimed invention provides a vaccine and method of immunizing a subject against infection by various species of Eimeria including E.maxima and E.tenella.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.